A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics

Clinical trial NCT01833923 · COMPLETED

Trial details

NCT number: NCT01833923
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2011-05-01
Primary completion: 2015-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.